PDCD1 and neoplasm: In conclusion, our data showing the presence of PD1intermediate EOMEShighTbetlow, as well as PD1+ memory cells in patients with tumor load above 10% bone marrow plasma cells could give an indication that checkpoint inhibition would be beneficial if given at the correct time when there are enough tumor responsive CD8+ T cells around.